Showing results (1651-1660 of 1,690) with videos related to
Sort By:
Pageof 169
Molecular Genetics and Metabolism Reports|June 21, 2018
De novo ATP1A3 and compound heterozygous NLRP3 mutations in a child with autism spectrum disorder, episodic fatigue and somnolence, and muckle-wells syndromeAlcy Torres, Catherine A Brownstein, Sahil K Tembulkar, et al.Circulation. Cardiovascular Interventions|October 18, 2024
Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis PatientsThomas Modine, Didier Tchétché, Nicolas M Van Mieghem, et al.European Heart Journal|April 27, 2007
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging studyVladimir Dzavík, Gad Cotter, Harmony R Reynolds, et al.Journal of the American College of Cardiology|February 14, 1998
Myonecrosis after revascularization proceduresR M Califf, A E Abdelmeguid, R E Kuntz, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 19, 2025
Late arrhythmic burden in patients with left bundle branch block after TAVR with the Evolut valveSilvia Mas-Peiro, Thibault Lhermusier, Marina Urena, et al.Clinical Psychological Science : a Journal of the Association for Psychological Science|April 11, 2024
Increase in Suicidal Thinking During COVID-19Rebecca G Fortgang, Shirley B Wang, Alexander J Millner, et al.Journal of Psychopathology and Clinical Science|May 18, 2026
Using smartphone surveys to predict next-week suicide attemptsMatthew K Nock, Evan M Kleiman, Kate H Bentley, et al.Journal of Thrombosis and Haemostasis : JTH|March 6, 2004
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI PilotJ H Alexander, C K Dyke, H Yang, et al.JAMA|November 4, 2004
Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement InitiativeDeepak L Bhatt, Matthew T Roe, Eric D Peterson, et al.Journal of Medicinal Chemistry|October 3, 2012
Application of structure-based drug design and parallel chemistry to identify selective, brain penetrant, in vivo active phosphodiesterase 9A inhibitorsMichelle M Claffey, Christopher J Helal, Patrick R Verhoest, et al.Pageof 169